Is Bal Pharma Ltd a good quality company?

MoneyWorks4Me analysed the past 10-year performance of Bal Pharma Ltd and arrived at the following conclusion.

Is the current market price of Bal Pharma Ltd a good price to buy it?

The 5-year analysis of Bal Pharma Ltd's performance infers.

What is Bal Pharma Ltd share price return in the past 10 years?

We analysed the performance of Bal Pharma Ltd share prices over the last 10 years. Here is what we found out:

What is a Financial Track Record? How to read this chart in order to understand the data present here?

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance

Difference between Standalone Basis and Consolidated basis? Which method is preferred for Bal Pharma Ltd

Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.

What is CAGR? What does CAGR table indicate for Bal Pharma Ltd?

Compounded average growth rate (CAGR) measures the average annual growth rate compounded year-on-year over a period of time.

Bal Pharma informs about outcome of board meeting

Bal Pharma Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 524824 | NSE: BALPHARMA

29 Jun 2019

Evaluate

Bal Pharma has informed that Board of Directors of the Company at their meeting held on 29/06/2019 has accepted the resignation of Anika Merciline from the position of Company Secretary and Compliance office, with immediate effect. She has cited personal reasons for her resignation.

The above information is a part of company’s filings submitted to BSE.

Related Bal Pharma Ltd. Links:

Analysis

Reports

News

Stock Price

Sector News